These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 12740151

  • 21. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
    Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B.
    Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
    Grøndahl ML, Borup R, Lee YB, Myrhøj V, Meinertz H, Sørensen S.
    Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect.
    O'Dea L, O'Brien F, Currie K, Hemsey G.
    Curr Med Res Opin; 2008 Oct; 24(10):2785-93. PubMed ID: 18727841
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.
    Santi D, Casarini L, Alviggi C, Simoni M.
    Front Endocrinol (Lausanne); 2017 Oct; 8():114. PubMed ID: 28620352
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2:1 ratio combination. Pharmacological characteristics and clinical applications.
    Bosch E.
    Expert Opin Biol Ther; 2010 Jun; 10(6):1001-9. PubMed ID: 20415593
    [Abstract] [Full Text] [Related]

  • 35. Ten years of clinical experiences with human gonadotropins.
    Cittadini E, Quartararo P, Catalano G.
    Acta Eur Fertil; 1974 Jun; 5(2):149-79. PubMed ID: 4411100
    [No Abstract] [Full Text] [Related]

  • 36. FSH and LH together in ovarian stimulation.
    Levi-Setti PE, Cavagna M, Baggiani A, Zannoni E, Colombo GV, Liprandi V.
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul 01; 115 Suppl 1():S34-9. PubMed ID: 15196714
    [Abstract] [Full Text] [Related]

  • 37. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age.
    Fábregues F, Creus M, Peñarrubia J, Manau D, Vanrell JA, Balasch J.
    Fertil Steril; 2006 Apr 01; 85(4):925-31. PubMed ID: 16580376
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P, Kovats T, Bernard A, Zadori J, Szmatona G, Kaali SG.
    Fertil Steril; 2008 Dec 01; 90(6):2133-7. PubMed ID: 18177866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.